Cardiac tissue engineering represents a groundbreaking field at the intersection of medicine, biology, and engineering, aiming to address the challenges associated with heart diseases and organ transplantation. As a response to the limited availability of donor organs and the intricate nature of the heart, scientists are exploring innovative approaches to create functional cardiac tissues in the laboratory. This involves the use of biomaterials, stem cells, and advanced fabrication techniques to construct three-dimensional structures that mimic the intricate architecture of the heart. The ultimate goal is to develop viable tissue replacements that can integrate seamlessly with the patient's own heart, promoting regeneration and restoring proper cardiac function. This promising avenue holds the potential to revolutionize the treatment of heart diseases, offering personalized solutions and reducing the dependency on traditional transplantation methods. While challenges remain, including achieving electrical integration and vascularization, cardiac tissue engineering represents a beacon of hope in the quest for more effective treatments for cardiovascular disorders.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India